.

H A .
.
, ,

.
(acetylsalicylic acid, ASA),
(aspirin),

40.000
3600 100 mg.
16.000 .
. 23
.
1899, Aspirin. "a"
acetyl () "spir" Spiraea ulmaria,
(
Spirsure) "in",
.

.
. 30-40
, 15-20 , .


2 (TXA2) ,
.


. - ,
, ,
.

.
. , ,

.


.
. ,
, , ,
HDL , ,
( ) ,
.
,
,
.

, .


.
-
.

Home | Load last record of this session | Clean fields |

Coronary heart disease risk using risk factor categories
Age

Sex

Male

Female

Choresterol

mg/dl

HDL-Chol

mg/dl

Blood pressure

Optimal (SBP<120)/(DBP<80)

Diabetes

No

Smoking

No

Upper GI bleeding risk

GI Risk factors

No ulcer history

NSAID use

No

CV Treatment
ASA

Yes

Clopidogrel

No

Warfarin

No
Calculate

2013 University of Zaragoza. IIS of Aragn. CIBERehd (Zaragoza). Spain

 ,

.

:
1. European Guidelines on cardiovascular disease prevention in clinical practice
(version 2012)
2. Guidelines of ACCF/AHA 2009 Performance Measures for Primary Prevention
of Cardiovascular Disease in Adults
3. Michael S.Lauer, M.D. Aspirin for primary prevention of coronary events. N
Engl J Med, 2002; 346: 1468 -1474
4. Karha, J., Rajagopal, V., Kottke-Marchant, K., Bhatt, D.L. Lack of effect of
enteric coating on aspirin-induced inhibition of platelet aggregation in
healthy volunteers. Am Heart J 2006, 151: 976. e7-11
5. Aspirin for primary prevention of cardiovascular disease events. Nemerovski
CW, Salinitri FD, Morbitzer KA, Moser LR. Pharmacotherapy. 2012 Nov;
32(11):1020-35.
6. Aspirin in the primary and secondary prevention of vascular disease:
collaborative meta-analysis of individual participant data from randomised
trials. Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L,
Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, et
al. Lancet. 2009 May 30; 373(9678):1849-60
7. Aspirin treatment failure: is this a real phenomenon? A review of the
aetiology and how to treat it. Shahid F, Chahal CA, Akhtar MJ. JRSM Short
Rep. 2013 Apr; 4(4):30. Epub 2013 Mar 27

8. Aspirin in the treatment and prevention of cardiovascular disease: past and

current perspectives and future directions. Hennekens CH, Dalen JE. Am J
Med. 2013 May;126(5):373-8.